- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
MBI’s CT agent shows promise
A liver-specific CT contrast agent under development at Molecular Biosystems (MBI) was featured at the biannual Contrast Media Research Conference, held Sept. 13 through 17 in Woodstock, VT. Animal studies have shown that the agent, MB-840, could help
A liver-specific CT contrast agent under development at Molecular Biosystems (MBI) was featured at the biannual Contrast Media Research Conference, held Sept. 13 through 17 in Woodstock, VT. Animal studies have shown that the agent, MB-840, could help clinicians identify and monitor primary and metastatic liver tumors as small as 1 to 2 mm, whereas water-soluble CT contrast agents can detect tumors no smaller than 20 mm. MB-840 could also help physicians find diseases of the hepatobiliary system, MBI said. The San Diego, CA, company expects to begin clinical trials for the agent next year, according to Dr. Howard Dittrich, executive vice president. MBI also developed Optison, an ultrasound contrast agent cleared by the FDA in 1997 (SCAN 1/14/98).
MRI-Based AI Radiomics Model Offers 'Robust' Prediction of Perineural Invasion in Prostate Cancer
July 26th 2024A model that combines MRI-based deep learning radiomics and clinical factors demonstrated an 84.8 percent ROC AUC and a 92.6 percent precision-recall AUC for predicting perineural invasion in prostate cancer cases.
Breast MRI Study Examines Common Factors with False Negatives and False Positives
July 24th 2024The absence of ipsilateral breast hypervascularity is three times more likely to be associated with false-negative findings on breast MRI and non-mass enhancement lesions have a 4.5-fold likelihood of being linked to false-positive results, according to new research.
Can Polyenergetic Reconstruction Help Resolve Streak Artifacts in Photon Counting CT?
July 22nd 2024New research looking at photon-counting computed tomography (PCCT) demonstrated significantly reduced variation and tracheal air density attenuation with polyenergetic reconstruction in contrast to monoenergetic reconstruction on chest CT.
